Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Fort Lauderdale, FL
SEC filing record 1 source field available
Fiscal year end
31 December
Sunshine Biopharma Inc. has filed 405 SEC EDGAR filings since 25 May 2007

SEC filing history

Showing 301-325 of 374 matching filings.

Per page
25
Current page
13
8-K File 000-52898

CURRENT REPORT

Filing date
14 Mar 2016
Reporting date
14 Mar 2016
Next action
Verify source filing
8-K File 000-52898

CURRENT REPORT

Filing date
28 Dec 2015
Reporting date
28 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-52898

QUARTERLY REPORT

Filing date
04 Nov 2015
Reporting date
30 Sep 2015
Next action
Verify source filing
8-K File 000-52898

CURRENT REPORT

Filing date
09 Oct 2015
Reporting date
08 Oct 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-52898

QUARTERLY REPORT

Filing date
06 Aug 2015
Reporting date
30 Jun 2015
Next action
Verify source filing
8-K File 000-52898

CURRENT REPORT

Filing date
04 Aug 2015
Reporting date
04 Aug 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14C File 000-52898

INFORMATION STATEMENT

Filing date
23 Jun 2015
Reporting date
25 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14C File 000-52898

PRELIMINARY PROXY STATEMENT

Filing date
08 Jun 2015
Reporting date
08 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
01 Jun 2015
Reporting date
27 May 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-52898

CURRENT REPORT

Filing date
01 Jun 2015
Reporting date
27 May 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-52898

QUARTERLY REPORT

Filing date
07 May 2015
Reporting date
31 Mar 2015
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
20 Mar 2015
Reporting date
20 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
20 Mar 2015
Reporting date
20 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 000-52898

ANNUAL REPORT

Filing date
11 Mar 2015
Reporting date
31 Dec 2014
Next action
Verify source filing
8-K File 000-52898

CURRENT REPORT

Filing date
24 Feb 2015
Reporting date
20 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
22 Jan 2015
Reporting date
09 Jan 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-52898

CURRENT REPORT

Filing date
19 Nov 2014
Reporting date
14 Nov 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-52898

QUARTERLY REPORT

Filing date
12 Nov 2014
Reporting date
30 Sep 2014
Next action
Verify source filing
10-Q File 000-52898

QUARTERLY REPORT

Filing date
12 Aug 2014
Reporting date
30 Jun 2014
Next action
Verify source filing
424B3 File 333-196191

PROSPECTUS

Filing date
28 Jul 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-196191

EFFECT filing

Filing date
23 Jul 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
21 Jul 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-196191

REGISTRATION STATEMENT

Filing date
03 Jul 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
02 Jul 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
20 Jun 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .